Everolimus NEW

Everolimus is a derivative of sirolimus, also known as 40-O-(2-hydroxyethyl)-rapamycin, or 40-O-(2-hydroxyethyl)-sirolimus. It belongs to the kinase drugs that interfere with cell communication to prevent tumor cell growth. It is an oral mammalian rapamycin (mTOR) inhibitor. In the past, it was mainly used clinically to prevent rejection reactions after kidney transplantation and heart transplantation.

Purchase process:

1. Contact the sales department to confirm the product name, quantity, price, packaging, etc.

2. After confirmation, remit the money to our company account and send detailed delivery information

3. Ship within 2 working days after payment and offer tracking number.

4. Customer confirms receipt

Rock

Whatsapp/ Signal:+8618829283179

Email: rock@horlden.com